Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Biotechnology Equipment

PUBLISHER: MarketsandMarkets | PRODUCT CODE: 1239423

Cover Image

PUBLISHER: MarketsandMarkets | PRODUCT CODE: 1239423

Cell Dissociation Market by Product (Trypsin, Papain, DNase, Hyaluronidase, Instruments), Tissue Type (Connective Tissue, Epithelial Tissue), End User (Pharma, Biopharma, Research Institutes) & Region- Global Forecasts to 2028

PUBLISHED:
PAGES: 196 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 4950
PDF (5-user License)
USD 6650
PDF (Corporate License)
USD 8150
PDF (Global License)
USD 10000

Add to Cart

Description

Table of Contents

The cell dissociation market is projected to grow from USD 0.6 billion in 2023 to USD 1.4 billion by 2028 at a CAGR of 17.8%. The key factors driving the growth of the cell dissociation market are the increase in recombinant therapeutics sourced from mammalian cells, the growing focus on personalized medicine, and increasing GMP certification approvals for cell therapy production facilities. Additionally, advancements in non-enzymatic tissue dissociation are expected to offer lucrative market opportunities.

"Enzymatic dissociation products segment to witness the highest growth during the forecast period."

Based on product, the cell dissociation market is segmented into enzymatic dissociation agents, non-enzymatic dissociation agents, and instruments & accessories. The enzymatic dissociation agents segment dominated the cell dissociation market in 2022. It is expected to hold the largest share till 2028. The expanding pool of operational entities in this segment and established protocols for using enzymatic dissociation agents are key contributors to market growth.

Non-enzymatic alternatives for cell dissociation are being developed to overcome the limitations of traditional enzymes. Instruments and accessories form a niche segment, with few manufacturers active.

"Connective tissue segment to register the highest growth in the cell dissociation market during the forecast period."

Based on tissue type, the cell dissociation market has been segmented into connective tissue, epithelial tissue, and other tissues (muscle tissue, lung tissue, and nerve tissue). Connective tissue dominated the cell dissociation market in 2022. The extensive research on connective tissues has ensured a high share of this segment. However, the epithelial tissue segment is expected to grow at the highest rate over the forecast period.

"Asia Pacific is estimated to register the highest CAGR during the forecast period."

The cell dissociation market is segmented into North America, Europe, the Asia Pacific (APAC), Latin America, and the Middle East & Africa (MEA). The Asia Pacific market is estimated to register the highest growth during the forecast period primarily due to the rising R&D investments in the pharmaceutical sectors of several emerging APAC countries, favorable regulatory guidelines & government support, lower manufacturing costs, and increasing incidence of diseases.

Breakdown of supply-side primary interviews, by company type, designation, and region:

  • By Respondent: Supply Side (20%) , Demand side (80%)
  • By Designation: C-level (20%), Director-level (25%), and Others (55%)
  • By Region: North America (40%), Europe (28%), AsiaPacific (20%), and Rest of the World(12%)

List of Companies Profiled in the Report

  • Merck KGaA (Germany)
  • Danaher Corporation (US)
  • Thermo Fisher Scientific, Inc. (US)
  • Corning Incorporated (US)
  • Becton, Dickinson and Company (US)
  • STEMCELL Technologies (Canada)
  • PromoCell GmbH (Germany)
  • Miltenyi Biotec (Germany)
  • ATCC (US)
  • HiMedia Laboratories (India)
  • PAN-Biotech (Germany)
  • CellSystems GmbH (Germany)
  • AMSBIO (England)
  • Neuromics (US)
  • VitaCyte, LLC. (US)
  • ALSTEM (US)
  • Biological Industries (Israel)
  • Gemini Bio (US)
  • Innovative Cell Technologies, Inc. (US)
  • Central Drug House (P) Ltd. (India)
  • Worthington Biochemical Corporation (US)
  • Capricorn Scientific (Germany)
  • Abeomics (US)
  • Genlantis, Inc. (US)

Research Coverage

This report studies the cell dissociation market based on product, tissue type, application, end user, and region. The report also analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total cell dissociation market. The report forecasts the revenue of the market segments with respect to four major regions.

Reasons to Buy the Report:

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on cell dissociation products offered by the top 25 players in the cell dissociation market. The report analyzes the cell dissociation market by product, tissue type, application, end user, and region.
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various securement devices across key geographic regions.
  • Market Diversification: Exhaustive information about untapped geographies, recent developments, and investments in the cell dissociation market
  • Competitive Assessment: In-depth assessment of market shares and strategies of the leading players in the cell dissociation market
Show more
Product Code: BT 6129

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS AND EXCLUSIONS
  • 1.3 STUDY SCOPE
  • 1.4 YEARS CONSIDERED
  • 1.5 CURRENCY CONSIDERED
  • 1.6 LIMITATIONS
  • 1.7 STAKEHOLDERS
  • 1.8 RECESSION IMPACT

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH APPROACH
    • FIGURE 1 RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
    • 2.1.2 PRIMARY DATA
    • FIGURE 2 BREAKDOWN OF PRIMARIES: CELL DISSOCIATION MARKET
  • 2.2 MARKET SIZE ESTIMATION
    • FIGURE 3 MARKET SIZE ESTIMATION: BOTTOM-UP (SUPPLY SIDE): COLLECTIVE REVENUE OF CELL DISSOCIATION COMPANIES
    • FIGURE 4 AVERAGE MARKET SIZE ESTIMATION, 2022
  • 2.3 GROWTH RATE ASSUMPTIONS/GROWTH FORECAST
    • FIGURE 5 CELL DISSOCIATION MARKET: CAGR PROJECTIONS, 2022-2027
    • FIGURE 6 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • 2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
    • FIGURE 7 DATA TRIANGULATION METHODOLOGY
  • 2.5 INSIGHTS FROM PRIMARIES
    • FIGURE 8 MARKET VALIDATION FROM PRIMARY EXPERTS
  • 2.6 RESEARCH ASSUMPTIONS
  • 2.7 RISK ASSESSMENT
  • 2.8 RECESSION IMPACT ANALYSIS
    • TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021-2027 (% GROWTH)

3 EXECUTIVE SUMMARY

    • FIGURE 9 CELL DISSOCIATION MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION)
    • FIGURE 10 CELL DISSOCIATION MARKET, BY TISSUE TYPE, 2023 VS. 2028 (USD MILLION)
    • FIGURE 11 CELL DISSOCIATION MARKET, BY APPLICATION, 2022 VS. 2026 (USD MILLION)
    • FIGURE 12 CELL DISSOCIATION MARKET, BY END USER, 2022 VS. 2026 (USD MILLION)
    • FIGURE 13 GEOGRAPHICAL SNAPSHOT

4 PREMIUM INSIGHTS

  • 4.1 CELL DISSOCIATION MARKET OVERVIEW
    • FIGURE 14 INCREASING INVESTMENTS AND FUNDING FOR CELL RESEARCH TO DRIVE MARKET
  • 4.2 NORTH AMERICA: CELL DISSOCIATION MARKET
    • FIGURE 15 ENZYMATIC DISSOCIATION AGENTS TO COMMAND LARGEST SHARE OF NORTH AMERICAN MARKET
  • 4.3 NORTH AMERICA: CELL DISSOCIATION MARKET, BY TISSUE TYPE, 2023 VS. 2028 (USD MILLION)
    • FIGURE 16 EPITHELIAL TISSUE SEGMENT TO GROW AT HIGHEST CAGR IN NORTH AMERICA

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 17 CELL DISSOCIATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • TABLE 2 CELL DISSOCIATION MARKET: IMPACT ANALYSIS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Increase in recombinant therapeutics sourced from mammalian cells
    • FIGURE 18 RISE IN MARKETED THERAPEUTICS, 2002 VS 2022
    • FIGURE 19 MARKETED THERAPEUTICS, BY ORIGIN, 2022
      • 5.2.1.2 Growing focus on personalized medicine
    • FIGURE 20 SHARE OF PERSONALIZED MEDICINES IN TOTAL NUMBER OF FDA-APPROVED NEW MOLECULAR ENTITIES, 2015-2021
      • 5.2.1.3 cGMP approvals for new cell therapy production facilities
    • TABLE 3 NEW GMP FACILITIES AND EXPANSIONS, 2017-2022
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 High cost of cell-based research
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Advancements in non-enzymatic tissue dissociation
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Limitations associated with dissociated cell culture
  • 5.3 TECHNOLOGY ANALYSIS
  • 5.4 SUPPLY/VALUE CHAIN ANALYSIS
    • FIGURE 21 CELL DISSOCIATION MARKET: VALUE CHAIN ANALYSIS
  • 5.5 ECOSYSTEM ANALYSIS
    • FIGURE 22 CELL DISSOCIATION MARKET: ECOSYSTEM ANALYSIS
  • 5.6 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 4 CELL DISSOCIATION MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 5.6.1 THREAT OF NEW ENTRANTS
    • 5.6.2 THREAT OF SUBSTITUTES
    • 5.6.3 BARGAINING POWER OF SUPPLIERS
    • 5.6.4 BARGAINING POWER OF BUYERS
    • 5.6.5 DEGREE OF COMPETITION
  • 5.7 REGULATORY ANALYSIS
    • 5.7.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 5 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 6 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 7 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 8 ROW: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.8 PRICING ANALYSIS
    • TABLE 9 AVERAGE SELLING PRICES OF KEY PLAYERS, BY PRODUCT (REAGENTS)
    • 5.8.1 AVERAGE SELLING PRICE TREND
    • TABLE 10 PRICING TRENDS FOR CELL DISSOCIATION REAGENTS OFFERED BY KEY PLAYERS
  • 5.9 KEY CONFERENCES & EVENTS, 2023-2024
    • TABLE 11 CELL DISSOCIATION CONFERENCES & EVENTS (2023-2024)
  • 5.10 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 5.10.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • FIGURE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF CELL DISSOCIATION PRODUCTS
    • 5.10.2 BUYING CRITERIA FOR CELL DISSOCIATION PRODUCTS
    • FIGURE 24 KEY BUYING CRITERIA FOR END USERS

6 CELL DISSOCIATION MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
    • TABLE 12 CELL DISSOCIATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • 6.2 ENZYMATIC DISSOCIATION AGENTS
    • TABLE 13 CELL DISSOCIATION MARKET FOR ENZYMATIC DISSOCIATION AGENTS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 14 CELL DISSOCIATION MARKET FOR ENZYMATIC DISSOCIATION AGENTS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 15 NORTH AMERICA: CELL DISSOCIATION MARKET FOR ENZYMATIC DISSOCIATION AGENTS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 16 EUROPE: CELL DISSOCIATION MARKET FOR ENZYMATIC DISSOCIATION AGENTS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 17 ASIA PACIFIC: CELL DISSOCIATION MARKET FOR ENZYMATIC DISSOCIATION AGENTS, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.2.1 COLLAGENASE
      • 6.2.1.1 Collagenase to hold largest share of enzymatic dissociation agents market
    • TABLE 18 CELL DISSOCIATION MARKET FOR COLLAGENASE, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 19 NORTH AMERICA: CELL DISSOCIATION MARKET FOR COLLAGENASE, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 20 EUROPE: CELL DISSOCIATION MARKET FOR COLLAGENASE, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 21 ASIA PACIFIC: CELL DISSOCIATION MARKET FOR COLLAGENASE, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.2.2 TRYPSIN
      • 6.2.2.1 Established protocols for using trypsin to contribute to segment growth
    • TABLE 22 CELL DISSOCIATION MARKET FOR TRYPSIN, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 23 NORTH AMERICA: CELL DISSOCIATION MARKET FOR TRYPSIN, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 24 EUROPE: CELL DISSOCIATION MARKET FOR TRYPSIN, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 25 ASIA PACIFIC: CELL DISSOCIATION MARKET FOR TRYPSIN, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.2.3 PAPAIN
      • 6.2.3.1 Benefits of papain-based dissociation to drive usage
    • TABLE 26 CELL DISSOCIATION MARKET FOR PAPAIN, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 27 NORTH AMERICA: CELL DISSOCIATION MARKET FOR PAPAIN, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 28 EUROPE: CELL DISSOCIATION MARKET FOR PAPAIN, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 29 ASIA PACIFIC: CELL DISSOCIATION MARKET FOR PAPAIN, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.2.4 ELASTASE
      • 6.2.4.1 Elastase to find frequent use in dissociating tissues containing extensive intercellular fiber networks
    • TABLE 30 CELL DISSOCIATION MARKET FOR ELASTASE, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 31 NORTH AMERICA: CELL DISSOCIATION MARKET FOR ELASTASE, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 32 EUROPE: CELL DISSOCIATION MARKET FOR ELASTASE, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 33 ASIA PACIFIC: CELL DISSOCIATION MARKET FOR ELASTASE, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.2.5 DNASE
      • 6.2.5.1 Increasing demand in single-cell suspensions to propel market
    • TABLE 34 CELL DISSOCIATION MARKET FOR DNASE, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 35 NORTH AMERICA: CELL DISSOCIATION MARKET FOR DNASE, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 36 EUROPE: CELL DISSOCIATION MARKET FOR DNASE, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 37 ASIA PACIFIC: CELL DISSOCIATION MARKET FOR DNASE, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.2.6 HYALURONIDASE
      • 6.2.6.1 Increasing use of hyaluronidase as supplement for tissue dissociation to support market growth
    • TABLE 38 CELL DISSOCIATION MARKET FOR HYALURONIDASE, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 39 NORTH AMERICA: CELL DISSOCIATION MARKET FOR HYALURONIDASE, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 40 EUROPE: CELL DISSOCIATION MARKET FOR HYALURONIDASE, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 41 ASIA PACIFIC: CELL DISSOCIATION MARKET FOR HYALURONIDASE, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.2.7 OTHER ENZYMES
    • TABLE 42 CELL DISSOCIATION MARKET FOR OTHER ENZYMES, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 43 NORTH AMERICA: CELL DISSOCIATION MARKET FOR OTHER ENZYMES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 44 EUROPE: CELL DISSOCIATION MARKET FOR OTHER ENZYMES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 45 ASIA PACIFIC: CELL DISSOCIATION MARKET FOR OTHER ENZYMES, BY COUNTRY, 2021-2028 (USD MILLION)
  • 6.3 NON-ENZYMATIC DISSOCIATION AGENTS
    • 6.3.1 HIGH YIELD AND OTHER BENEFITS TO DRIVE DEMAND FOR NON-ENZYMATIC PRODUCTS
    • TABLE 46 CELL DISSOCIATION MARKET FOR NON-ENZYMATIC DISSOCIATION AGENTS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 47 NORTH AMERICA: CELL DISSOCIATION MARKET FOR NON-ENZYMATIC DISSOCIATION AGENTS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 48 EUROPE: CELL DISSOCIATION MARKET FOR NON-ENZYMATIC DISSOCIATION AGENTS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 49 ASIA PACIFIC: CELL DISSOCIATION MARKET FOR NON-ENZYMATIC DISSOCIATION AGENTS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 6.4 INSTRUMENTS & ACCESSORIES
    • 6.4.1 INTRODUCTION OF ADVANCED BENCHTOP INSTRUMENTS TO PROPEL MARKET
    • TABLE 50 CELL DISSOCIATION MARKET FOR INSTRUMENTS & ACCESSORIES, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 51 NORTH AMERICA: CELL DISSOCIATION MARKET FOR INSTRUMENTS & ACCESSORIES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 52 EUROPE: CELL DISSOCIATION MARKET FOR INSTRUMENTS & ACCESSORIES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 53 ASIA PACIFIC: CELL DISSOCIATION MARKET FOR INSTRUMENTS & ACCESSORIES, BY COUNTRY, 2021-2028 (USD MILLION)

7 CELL DISSOCIATION MARKET, BY TISSUE TYPE

  • 7.1 INTRODUCTION
    • TABLE 54 CELL DISSOCIATION MARKET, BY TISSUE TYPE, 2021-2028 (USD MILLION)
  • 7.2 CONNECTIVE TISSUE
    • 7.2.1 EXTENSIVE RESEARCH ON CONNECTIVE TISSUES TO PROPEL SEGMENT GROWTH
    • FIGURE 25 NUMBER OF RESEARCH ARTICLES FOR CONNECTIVE TISSUE, 2020-2022
    • TABLE 55 CELL DISSOCIATION MARKET FOR CONNECTIVE TISSUE, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 56 NORTH AMERICA: CELL DISSOCIATION MARKET FOR CONNECTIVE TISSUE, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 57 EUROPE: CELL DISSOCIATION MARKET FOR CONNECTIVE TISSUE, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 58 ASIA PACIFIC: CELL DISSOCIATION MARKET FOR CONNECTIVE TISSUE, BY COUNTRY, 2021-2028 (USD MILLION)
  • 7.3 EPITHELIAL TISSUE
    • 7.3.1 NEW PROTOCOLS TO COMBAT DISSOCIATION-INDUCED CHANGES IN EPITHELIAL CELLS LIKELY TO SUPPORT GROWTH
    • TABLE 59 CELL DISSOCIATION MARKET FOR EPITHELIAL TISSUE, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 60 NORTH AMERICA: CELL DISSOCIATION MARKET FOR EPITHELIAL TISSUE, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 61 EUROPE: CELL DISSOCIATION MARKET FOR EPITHELIAL TISSUE, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 62 ASIA PACIFIC: CELL DISSOCIATION MARKET FOR EPITHELIAL TISSUE, BY COUNTRY, 2021-2028 (USD MILLION)
  • 7.4 OTHER TISSUES
    • TABLE 63 CELL DISSOCIATION MARKET FOR OTHER TISSUES, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 64 NORTH AMERICA: CELL DISSOCIATION MARKET FOR OTHER TISSUES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 65 EUROPE: CELL DISSOCIATION MARKET FOR OTHER TISSUES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 66 ASIA PACIFIC: CELL DISSOCIATION MARKET FOR OTHER TISSUES, BY COUNTRY, 2021-2028 (USD MILLION)

8 CELL DISSOCIATION MARKET, BY APPLICATION

  • 8.1 INTRODUCTION
    • TABLE 67 CELL DISSOCIATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • 8.2 TISSUE DISSOCIATION
    • 8.2.1 INCREASING USE OF TISSUE DISSOCIATION PRODUCTS IN SINGLE-CELL ANALYSIS TO CONTRIBUTE TO SEGMENT GROWTH
    • TABLE 68 TISSUE DISSOCIATION MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 69 NORTH AMERICA: TISSUE DISSOCIATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 70 EUROPE: TISSUE DISSOCIATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 71 ASIA PACIFIC: TISSUE DISSOCIATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • 8.3 CELL DETACHMENT
    • 8.3.1 USE OF CELL DETACHMENT PRODUCTS IN ADHERENT CELL CULTURES TO DRIVE MARKET
    • TABLE 72 CELL DETACHMENT MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 73 NORTH AMERICA: CELL DETACHMENT MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 74 EUROPE: CELL DETACHMENT MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 75 ASIA PACIFIC: CELL DETACHMENT MARKET, BY COUNTRY, 2021-2028 (USD MILLION)

9 CELL DISSOCIATION MARKET, BY END USER

  • 9.1 INTRODUCTION
    • TABLE 76 CELL DISSOCIATION MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    • 9.2.1 PHARMA & BIOTECH COMPANIES TO HOLD LARGEST MARKET SHARE
    • TABLE 77 CELL DISSOCIATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 78 NORTH AMERICA: CELL DISSOCIATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 79 EUROPE: CELL DISSOCIATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 80 ASIA PACIFIC: CELL DISSOCIATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
  • 9.3 RESEARCH & ACADEMIC INSTITUTES
    • 9.3.1 RISING FUNDING FOR CELL-BASED RESEARCH TO DRIVE MARKET
    • TABLE 81 CELL DISSOCIATION MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 82 NORTH AMERICA: CELL DISSOCIATION MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 83 EUROPE: CELL DISSOCIATION MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 84 ASIA PACIFIC: CELL DISSOCIATION MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION)
  • 9.4 OTHER END USERS
    • TABLE 85 CELL DISSOCIATION MARKET FOR OTHER END USERS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 86 NORTH AMERICA: CELL DISSOCIATION MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 87 EUROPE: CELL DISSOCIATION MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 88 ASIA PACIFIC: CELL DISSOCIATION MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION)

10 CELL DISSOCIATION MARKET, BY REGION

  • 10.1 INTRODUCTION
    • TABLE 89 CELL DISSOCIATION MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 10.2 NORTH AMERICA
    • 10.2.1 RECESSION IMPACT
    • FIGURE 26 NORTH AMERICA: CELL DISSOCIATION MARKET SNAPSHOT
    • TABLE 90 NORTH AMERICA: CELL DISSOCIATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 91 NORTH AMERICA: CELL DISSOCIATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 92 NORTH AMERICA: ENZYMATIC DISSOCIATION AGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 93 NORTH AMERICA: CELL DISSOCIATION MARKET, BY TISSUE TYPE, 2021-2028 (USD MILLION)
    • TABLE 94 NORTH AMERICA: CELL DISSOCIATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 95 NORTH AMERICA: CELL DISSOCIATION MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.2.2 US
      • 10.2.2.1 US to dominate North American market
    • TABLE 96 US: CELL DISSOCIATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 97 US: ENZYMATIC DISSOCIATION AGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 98 US: CELL DISSOCIATION MARKET, BY TISSUE TYPE, 2021-2028 (USD MILLION)
    • TABLE 99 US: CELL DISSOCIATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 100 US: CELL DISSOCIATION MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.2.3 CANADA
      • 10.2.3.1 Advancements in regenerative medicine to drive market
    • TABLE 101 CANADA: CELL DISSOCIATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 102 CANADA: ENZYMATIC DISSOCIATION AGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 103 CANADA: CELL DISSOCIATION MARKET, BY TISSUE TYPE, 2021-2028 (USD MILLION)
    • TABLE 104 CANADA: CELL DISSOCIATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 105 CANADA: CELL DISSOCIATION MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 10.3 EUROPE
    • 10.3.1 RECESSION IMPACT
    • TABLE 106 EUROPE: CELL DISSOCIATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 107 EUROPE: CELL DISSOCIATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 108 EUROPE: ENZYMATIC DISSOCIATION AGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 109 EUROPE: CELL DISSOCIATION MARKET, BY TISSUE TYPE, 2021-2028 (USD MILLION)
    • TABLE 110 EUROPE: CELL DISSOCIATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 111 EUROPE: CELL DISSOCIATION MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.2 GERMANY
      • 10.3.2.1 Germany to hold largest share of European market
    • TABLE 112 GERMANY: CELL DISSOCIATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 113 GERMANY: ENZYMATIC DISSOCIATION AGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 114 GERMANY: CELL DISSOCIATION MARKET, BY TISSUE TYPE, 2021-2028 (USD MILLION)
    • TABLE 115 GERMANY: CELL DISSOCIATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 116 GERMANY: CELL DISSOCIATION MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.3 UK
      • 10.3.3.1 Government investments in biotech industry to support market growth
    • TABLE 117 UK: CELL DISSOCIATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 118 UK: ENZYMATIC DISSOCIATION AGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 119 UK: CELL DISSOCIATION MARKET, BY TISSUE TYPE, 2021-2028 (USD MILLION)
    • TABLE 120 UK: CELL DISSOCIATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 121 UK: CELL DISSOCIATION MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.4 FRANCE
      • 10.3.4.1 Increasing R&D investments by key players to boost market
    • TABLE 122 FRANCE: CELL DISSOCIATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 123 FRANCE: ENZYMATIC DISSOCIATION AGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 124 FRANCE: CELL DISSOCIATION MARKET, BY TISSUE TYPE, 2021-2028 (USD MILLION)
    • TABLE 125 FRANCE: CELL DISSOCIATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 126 FRANCE: CELL DISSOCIATION MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.5 ITALY
      • 10.3.5.1 Large life science research base in Italy to boost market prospects
    • TABLE 127 ITALY: CELL DISSOCIATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 128 ITALY: ENZYMATIC DISSOCIATION AGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 129 ITALY: CELL DISSOCIATION MARKET, BY TISSUE TYPE, 2021-2028 (USD MILLION)
    • TABLE 130 ITALY: CELL DISSOCIATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 131 ITALY: CELL DISSOCIATION MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.6 SPAIN
      • 10.3.6.1 Increasing funding from private and public organizations to aid market growth
    • TABLE 132 SPAIN: CELL DISSOCIATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 133 SPAIN: ENZYMATIC DISSOCIATION AGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 134 SPAIN: CELL DISSOCIATION MARKET, BY TISSUE TYPE, 2021-2028 (USD MILLION)
    • TABLE 135 SPAIN: CELL DISSOCIATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 136 SPAIN: CELL DISSOCIATION MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.7 REST OF EUROPE
    • TABLE 137 ROE: CELL DISSOCIATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 138 ROE: ENZYMATIC DISSOCIATION AGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 139 ROE: CELL DISSOCIATION MARKET, BY TISSUE TYPE, 2021-2028 (USD MILLION)
    • TABLE 140 ROE: CELL DISSOCIATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 141 ROE: CELL DISSOCIATION MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 10.4 ASIA PACIFIC
    • 10.4.1 RECESSION IMPACT
    • FIGURE 27 ASIA PACIFIC: CELL DISSOCIATION MARKET SNAPSHOT
    • TABLE 142 ASIA PACIFIC: CELL DISSOCIATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 143 ASIA PACIFIC: CELL DISSOCIATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 144 ASIA PACIFIC: ENZYMATIC DISSOCIATION AGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 145 ASIA PACIFIC: CELL DISSOCIATION MARKET, BY TISSUE TYPE, 2021-2028 (USD MILLION)
    • TABLE 146 ASIA PACIFIC: CELL DISSOCIATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 147 ASIA PACIFIC: CELL DISSOCIATION MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.4.2 CHINA
      • 10.4.2.1 China to dominate APAC market
    • TABLE 148 CHINA: CELL DISSOCIATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 149 CHINA: ENZYMATIC DISSOCIATION AGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 150 CHINA: CELL DISSOCIATION MARKET, BY TISSUE TYPE, 2021-2028 (USD MILLION)
    • TABLE 151 CHINA: CELL DISSOCIATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 152 CHINA: CELL DISSOCIATION MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.4.3 JAPAN
      • 10.4.3.1 Strategic developments by companies to drive market
    • TABLE 153 JAPAN: CELL DISSOCIATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 154 JAPAN: ENZYMATIC DISSOCIATION AGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 155 JAPAN: CELL DISSOCIATION MARKET, BY TISSUE TYPE, 2021-2028 (USD MILLION)
    • TABLE 156 JAPAN: CELL DISSOCIATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 157 JAPAN: CELL DISSOCIATION MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.4.4 INDIA
      • 10.4.4.1 Growing life sciences industry to push growth
    • TABLE 158 INDIA: CELL DISSOCIATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 159 INDIA: ENZYMATIC DISSOCIATION AGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 160 INDIA: CELL DISSOCIATION MARKET, BY TISSUE TYPE, 2021-2028 (USD MILLION)
    • TABLE 161 INDIA: CELL DISSOCIATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 162 INDIA: CELL DISSOCIATION MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.4.5 AUSTRALIA
      • 10.4.5.1 New cell/tissue culture technologies to promote market growth
    • TABLE 163 AUSTRALIA: CELL DISSOCIATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 164 AUSTRALIA: ENZYMATIC DISSOCIATION AGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 165 AUSTRALIA: CELL DISSOCIATION MARKET, BY TISSUE TYPE, 2021-2028 (USD MILLION)
    • TABLE 166 AUSTRALIA: CELL DISSOCIATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 167 AUSTRALIA: CELL DISSOCIATION MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.4.6 SOUTH KOREA
      • 10.4.6.1 Increasing pharmaceutical and biotech R&D investment to bolster market
    • TABLE 168 SOUTH KOREA: CELL DISSOCIATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 169 SOUTH KOREA: ENZYMATIC DISSOCIATION AGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 170 SOUTH KOREA: CELL DISSOCIATION MARKET, BY TISSUE TYPE, 2021-2028 (USD MILLION)
    • TABLE 171 SOUTH KOREA: CELL DISSOCIATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 172 SOUTH KOREA: CELL DISSOCIATION MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.4.7 REST OF ASIA PACIFIC
    • TABLE 173 ROAPAC: CELL DISSOCIATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 174 ROAPAC: ENZYMATIC DISSOCIATION AGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 175 ROAPAC: CELL DISSOCIATION MARKET, BY TISSUE TYPE, 2021-2028 (USD MILLION)
    • TABLE 176 ROAPAC: CELL DISSOCIATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 177 ROAPAC: CELL DISSOCIATION MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 10.5 LATIN AMERICA
    • 10.5.1 GOVERNMENT INVESTMENTS AND FAVORABLE FUNDING SCENARIO TO PROPEL MARKET
    • 10.5.2 RECESSION IMPACT
    • TABLE 178 LATIN AMERICA: CELL DISSOCIATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 179 LATIN AMERICA: ENZYMATIC DISSOCIATION AGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 180 LATIN AMERICA: CELL DISSOCIATION MARKET, BY TISSUE TYPE, 2021-2028 (USD MILLION)
    • TABLE 181 LATIN AMERICA: CELL DISSOCIATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 182 LATIN AMERICA: CELL DISSOCIATION MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 10.6 MIDDLE EAST & AFRICA
    • 10.6.1 INCREASING R&D FUNDING FOR STEM CELL THERAPY TO BOOST MARKET
    • 10.6.2 RECESSION IMPACT
    • TABLE 183 MIDDLE EAST & AFRICA: CELL DISSOCIATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 184 MIDDLE EAST & AFRICA: ENZYMATIC DISSOCIATION AGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 185 MIDDLE EAST & AFRICA: CELL DISSOCIATION MARKET, BY TISSUE TYPE, 2021-2028 (USD MILLION)
    • TABLE 186 MIDDLE EAST & AFRICA: CELL DISSOCIATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 187 MIDDLE EAST & AFRICA: CELL DISSOCIATION MARKET, BY END USER, 2021-2028 (USD MILLION)

11 COMPETITIVE LANDSCAPE

  • 11.1 INTRODUCTION
  • 11.2 RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS
    • FIGURE 28 CELL DISSOCIATION MARKET: STRATEGIES ADOPTED BY KEY PLAYERS
  • 11.3 MARKET SHARE ANALYSIS
    • FIGURE 29 CELL DISSOCIATION MARKET: MARKET SHARE ANALYSIS OF KEY PLAYERS (2022)
    • TABLE 188 CELL DISSOCIATION MARKET: DEGREE OF COMPETITION
  • 11.4 REVENUE ANALYSIS
    • FIGURE 30 REVENUE ANALYSIS OF TOP FIVE MARKET PLAYERS (2020-2022)
  • 11.5 COMPANY EVALUATION QUADRANT (2022)
    • 11.5.1 STARS
    • 11.5.2 EMERGING LEADERS
    • 11.5.3 PERVASIVE PLAYERS
    • 11.5.4 PARTICIPANTS
    • FIGURE 31 CELL DISSOCIATION MARKET: COMPANY EVALUATION MATRIX, 2022
  • 11.6 COMPANY EVALUATION QUADRANT FOR START-UPS/SMES (2022)
    • 11.6.1 PROGRESSIVE COMPANIES
    • 11.6.2 STARTING BLOCKS
    • 11.6.3 RESPONSIVE COMPANIES
    • 11.6.4 DYNAMIC COMPANIES
    • FIGURE 32 CELL DISSOCIATION MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2022
  • 11.7 COMPETITIVE BENCHMARKING OF START-UPS/SMES
    • TABLE 189 CELL DISSOCIATION MARKET: DETAILED LIST OF KEY START-UPS/SMES
    • TABLE 190 CELL DISSOCIATION MARKET: COMPETITIVE BENCHMARKING OF KEY START-UPS/SMES
  • 11.8 COMPETITIVE SCENARIO AND TRENDS
    • 11.8.1 PRODUCT LAUNCHES
    • TABLE 191 CELL DISSOCIATION MARKET: PRODUCT LAUNCHES, JANUARY 2020 TO JANUARY 2023
    • 11.8.2 DEALS
    • TABLE 192 CELL DISSOCIATION MARKET: DEALS, JANUARY 2020 TO JANUARY 2023

12 COMPANY PROFILES

  • 12.1 KEY PLAYERS

(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*

    • 12.1.1 THERMO FISHER SCIENTIFIC
    • TABLE 193 THERMO FISHER SCIENTIFIC: BUSINESS OVERVIEW
    • FIGURE 33 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2021)
    • 12.1.2 MERCK KGAA
    • TABLE 194 MERCK KGAA: BUSINESS OVERVIEW
    • FIGURE 34 MERCK KGAA: COMPANY SNAPSHOT (2021)
    • 12.1.3 CYTIVA (DANAHER CORPORATION)
    • TABLE 195 CYTIVA: BUSINESS OVERVIEW
    • FIGURE 35 DANAHER CORPORATION: COMPANY SNAPSHOT (2021)
    • 12.1.4 BECTON, DICKINSON AND COMPANY
    • TABLE 196 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
    • FIGURE 36 BD: COMPANY SNAPSHOT (2021)
    • 12.1.5 CORNING INC.
    • TABLE 197 CORNING INC.: BUSINESS OVERVIEW
    • FIGURE 37 CORNING INC.: COMPANY SNAPSHOT (2020)
    • 12.1.6 STEMCELL TECHNOLOGIES
    • TABLE 198 STEMCELL TECHNOLOGIES: BUSINESS OVERVIEW
    • 12.1.7 PROMOCELL GMBH
    • TABLE 199 PROMOCELL GMBH: BUSINESS OVERVIEW
    • 12.1.8 MILTENYI BIOTEC
    • TABLE 200 MILTENYI BIOTEC: BUSINESS OVERVIEW
    • 12.1.9 ATCC
    • TABLE 201 ATCC: BUSINESS OVERVIEW
    • 12.1.10 HIMEDIA LABORATORIES
    • TABLE 202 HIMEDIA LABORATORIES: BUSINESS OVERVIEW
    • 12.1.11 PAN-BIOTECH
    • TABLE 203 PAN-BIOTECH: BUSINESS OVERVIEW
    • 12.1.12 CELLSYSTEMS GMBH
    • TABLE 204 CELLSYSTEMS: BUSINESS OVERVIEW
    • 12.1.13 AMSBIO
    • TABLE 205 AMSBIO: BUSINESS OVERVIEW
    • 12.1.14 NEUROMICS
    • TABLE 206 NEUROMICS: BUSINESS OVERVIEW
  • Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
  • 12.2 OTHER PLAYERS
    • 12.2.1 VITACYTE
    • 12.2.2 ALSTEMBIO
    • 12.2.3 BIOLOGICAL INDUSTRIES (SARTORIUS)
    • 12.2.4 GEMINIBIO
    • 12.2.5 INNOVATIVE CELL TECHNOLOGIES, INC.
    • 12.2.6 CENTRAL DRUG HOUSE (P) LTD.
    • 12.2.7 WORTHINGTON BIOCHEMICAL CORPORATION
    • 12.2.8 CAPRICORN SCIENTIFIC
    • 12.2.9 ABEOMICS
    • 12.2.10 GENLANTIS

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 CUSTOMIZATION OPTIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!